Cite
Chen L, Xi L, Jiang J, et al. Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial. Front Med. 2021;doi: 10.1007/s11684-021-0855-4.
Chen, L., Xi, L., Jiang, J., Yin, R., Qu, P., Li, X., Wan, X., Chen, Y., Hu, D., Mao, Y., Pan, Z., Cheng, X., Wang, X., Li, Q., Weng, D., Zhang, X., Zhang, H., Ping, Q., Liu, X., Xie, X., Kong, B., Ma, D., & Lu, W. (2021). Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial. Frontiers of medicine, . https://doi.org/10.1007/s11684-021-0855-4
Chen, Lili, et al. "Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial." Frontiers of medicine vol. (2021). doi: https://doi.org/10.1007/s11684-021-0855-4
Chen L, Xi L, Jiang J, Yin R, Qu P, Li X, Wan X, Chen Y, Hu D, Mao Y, Pan Z, Cheng X, Wang X, Li Q, Weng D, Zhang X, Zhang H, Ping Q, Liu X, Xie X, Kong B, Ma D, Lu W. Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial. Front Med. 2021 Jun 28; doi: 10.1007/s11684-021-0855-4. Epub 2021 Jun 28. PMID: 34181195.
Copy
Download .nbib